サインイン

The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.

The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by binding to the same receptor. This prevents the agonist drug from activating the receptor and producing its intended effect. For example, naloxone, a competitive antagonist, can block the effects of opioid drugs by binding to opioid receptors and reversing their activation.

In addition, functional or physiological antagonism occurs when a drug binds to a different receptor and produces a physiological response that opposes the effect of the agonist-bound receptor. For example, histamine stimulates acid secretion, while omeprazole prevents acid secretion by inhibiting the proton pump. These drugs can be considered functional antagonists.

Some drugs follow chemical antagonism, which involves the combination of two drugs to form an inactive product. Examples include chelating agents like dimercaprol, which bind to heavy metals and reduce their toxicity. The neutralizing antibody infliximab, which sequesters the inflammatory cytokine tumor necrosis factor (TNF), has an anti-inflammatory effect.

Antagonism can also occur through pharmacokinetic interactions, where one drug affects another drug's absorption, distribution, metabolism, or elimination. For instance, if a drug increases the metabolism or elimination of another drug, it can decrease the concentration and effectiveness of the second drug, leading to antagonistic effects.

タグ
AntagonismDrug InteractionReceptor BindingAllosteric ModulationFunctional InteractionChemical ReactionsPharmacokinetic ProcessesReceptor AntagonismCompetitive AntagonistOpioid ReceptorsPhysiological AntagonismChelating AgentsInfliximabTumor Necrosis Factor TNFDrug Metabolism

章から 4:

article

Now Playing

4.14 : Combined Effects of Drugs: Antagonism

薬力学

7.5K 閲覧数

article

4.1 : 薬物作用の原則

薬力学

5.4K 閲覧数

article

4.2 : 薬物作用の標的:概要

薬力学

5.2K 閲覧数

article

4.3 : シグナル伝達:概要

薬力学

8.0K 閲覧数

article

4.4 : トランスデューサーメカニズム:Gタンパク質共役受容体

薬力学

1.6K 閲覧数

article

4.5 : リガンド依存性イオンチャネル受容体:ゲーティング機構

薬力学

1.9K 閲覧数

article

4.6 : トランスデューサーメカニズム:酵素結合受容体

薬力学

2.2K 閲覧数

article

4.7 : トランスデューサーメカニズム:核内受容体

薬力学

1.2K 閲覧数

article

4.8 : 用量反応関係:概要

薬力学

2.7K 閲覧数

article

4.9 : 用量反応関係:効力と効能

薬力学

3.9K 閲覧数

article

4.10 : 用量反応関係:選択性と特異性

薬力学

6.1K 閲覧数

article

4.11 : 治療指数

薬力学

3.8K 閲覧数

article

4.12 : 薬物-受容体相互作用:アゴニスト

薬力学

2.2K 閲覧数

article

4.13 : 薬物-受容体相互作用:アンタゴニスト

薬力学

2.4K 閲覧数

article

4.15 : 薬物の複合効果:シナジー

薬力学

3.0K 閲覧数

See More

JoVE Logo

個人情報保護方針

利用規約

一般データ保護規則

研究

教育

JoVEについて

Copyright © 2023 MyJoVE Corporation. All rights reserved